Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Aplaviroc is a human cellular CC chemokine receptor 5 (CCR5) entry inhibitor. Aplaviroc binds specifically to CCR5 and demonstrates potent anti-human immunodeficiency virus activity in vitro in the subnanomolar range. In vitro studies show that aplaviroc selectively inhibits the binding of a particular monoclonal antibody, 45531, to CCR5.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,140.00 | |
50 mg | 10-14 weeks | $ 1,490.00 | |
100 mg | 10-14 weeks | $ 2,360.00 |
Description | Aplaviroc is a human cellular CC chemokine receptor 5 (CCR5) entry inhibitor. Aplaviroc binds specifically to CCR5 and demonstrates potent anti-human immunodeficiency virus activity in vitro in the subnanomolar range. In vitro studies show that aplaviroc selectively inhibits the binding of a particular monoclonal antibody, 45531, to CCR5. |
Targets&IC50 | HIV-1 (MOKW):0.2 nM (IC50), HIV-1 (JRFL):0.1 nM (IC50), HIV-1 (Ba-L):0.4 nM (IC50) |
Synonyms | AK602, AK 602, GW873140A, GW-873140, GW873140, AK-602, Aplaviroc HCl |
Molecular Weight | 614.17 |
Formula | C33H44ClN3O6 |
CAS No. | 461023-63-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aplaviroc hydrochloride 461023-63-2 AK602 Aplaviroc Hydrochloride AK 602 GW873140A GW-873140 GW873140 GW 873140 AK-602 Aplaviroc HCl inhibitor inhibit